Sign inGet started

Umstead John V.

Insider CIK 1967910 · GTHX Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GTHX G1 Therapeutics, Inc. D To issuer deriv2024-09-182024-09-186,000— $00SEC↗
GTHX G1 Therapeutics, Inc. D To issuer deriv2024-09-182024-09-1874,500— $00SEC↗
GTHX G1 Therapeutics, Inc. D To issuer deriv2024-09-182024-09-18100,000— $00SEC↗
GTHX G1 Therapeutics, Inc. U Tender2024-09-182024-09-1819,331— $00SEC↗
GTHX G1 Therapeutics, Inc. D To issuer2024-09-182024-09-18168,387— $019,331SEC↗
GTHX G1 Therapeutics, Inc. S Sale2024-07-052024-07-08527$2.51 $1.3K187,718SEC↗
GTHX G1 Therapeutics, Inc. A Award2024-07-012024-07-0335,000— $0188,245SEC↗
GTHX G1 Therapeutics, Inc. S Sale2024-05-132024-05-158,151$4.79 $39.0K153,245SEC↗
GTHX G1 Therapeutics, Inc. A Award2024-03-202024-03-2237,500— $0161,396SEC↗
GTHX G1 Therapeutics, Inc. S Sale2024-03-182024-03-206,547$3.02 $19.8K123,896SEC↗
GTHX G1 Therapeutics, Inc. S Sale2024-01-042024-01-08111$2.94 $326130,443SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2024-01-032024-01-0874,500— $074,500SEC↗
GTHX G1 Therapeutics, Inc. A Award2024-01-032024-01-0837,300— $0131,186SEC↗
GTHX G1 Therapeutics, Inc. S Sale2024-01-032024-01-08253$3.12 $789130,933SEC↗
GTHX G1 Therapeutics, Inc. S Sale2024-01-032024-01-08379$3.12 $1.2K130,554SEC↗
GTHX G1 Therapeutics, Inc. A Award2023-05-102023-05-1235,000— $093,886SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2023-03-152023-03-17100,000— $0100,000SEC↗
GTHX G1 Therapeutics, Inc. A Award2023-03-152023-03-1750,000— $058,886SEC↗